UBS Sees PharMerica As A 'Show-Me' Story, Downgrades To Neutral

By: via Benzinga
UBS’ A.J. Rice downgraded the rating for PharMerica Corporation (NYSE: PMC) from Buy to Neutral, while reducing the price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.